Dialysis water treated by reverse osmosis decreases the levels of C-reactive protein in uremic patients

Atherosclerosis is a major complication of chronic renal failure. Microinflammation is involved in atherogenesis and is associated with uremia and dialysis. The role of dialysate water contamination in inducing inflammation has been debated. Our aim was to study inflammatory markers in patients on c...

Full description

Bibliographic Details
Main Authors: F.S. Thomé, M. Senger, C. Garcez, J. Garcez, C. Chemello, R.C. Manfro
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2005-05-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2005000500018
_version_ 1811338872550850560
author F.S. Thomé
M. Senger
C. Garcez
J. Garcez
C. Chemello
R.C. Manfro
author_facet F.S. Thomé
M. Senger
C. Garcez
J. Garcez
C. Chemello
R.C. Manfro
author_sort F.S. Thomé
collection DOAJ
description Atherosclerosis is a major complication of chronic renal failure. Microinflammation is involved in atherogenesis and is associated with uremia and dialysis. The role of dialysate water contamination in inducing inflammation has been debated. Our aim was to study inflammatory markers in patients on chronic dialysis, before and 3 to 6 months after switching the water purification system from deionization to reverse osmosis. Patients had demographic, clinical and nutritional information collected and blood drawn for determination of albumin, ferritin, C-reactive protein (CRP), interleukin-6, and tumor necrosis factor-alpha in both situations. Acceptable levels of water purity were less than 200 colony-forming units of bacteria and less than 1 ng/ml of endotoxin. Sixteen patients died. They had higher median CRP (26.6 vs 11.2 mg/dl, P = 0.007) and lower median albumin levels (3.1 vs 3.9 g/l, P < 0.05) compared to the 31 survivors. Eight patients were excluded because of obvious inflammatory conditions. From the 23 remaining patients (mean age ± SD: 51.3 ± 13.9 years), 18 had a decrease in CRP after the water treatment system was changed. Overall, median CRP was lower with reverse osmosis than with deionization (13.2 vs 4.5 mg/l, P = 0.022, N = 23). There was no difference in albumin, cytokines, subjective global evaluation, or clinical and biochemical parameters. In conclusion, uremic patients presented a clinically significant reduction in CRP levels when dialysate water purification system switched from deionization to reverse osmosis. It is possible that better water treatments induce less inflammation and eventually less atherosclerosis in hemodialysis patients.
first_indexed 2024-04-13T18:18:03Z
format Article
id doaj.art-6df4306f8bab40138af656feeac80f3e
institution Directory Open Access Journal
issn 0100-879X
1414-431X
language English
last_indexed 2024-04-13T18:18:03Z
publishDate 2005-05-01
publisher Associação Brasileira de Divulgação Científica
record_format Article
series Brazilian Journal of Medical and Biological Research
spelling doaj.art-6df4306f8bab40138af656feeac80f3e2022-12-22T02:35:37ZengAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research0100-879X1414-431X2005-05-0138578979410.1590/S0100-879X2005000500018Dialysis water treated by reverse osmosis decreases the levels of C-reactive protein in uremic patientsF.S. ThoméM. SengerC. GarcezJ. GarcezC. ChemelloR.C. ManfroAtherosclerosis is a major complication of chronic renal failure. Microinflammation is involved in atherogenesis and is associated with uremia and dialysis. The role of dialysate water contamination in inducing inflammation has been debated. Our aim was to study inflammatory markers in patients on chronic dialysis, before and 3 to 6 months after switching the water purification system from deionization to reverse osmosis. Patients had demographic, clinical and nutritional information collected and blood drawn for determination of albumin, ferritin, C-reactive protein (CRP), interleukin-6, and tumor necrosis factor-alpha in both situations. Acceptable levels of water purity were less than 200 colony-forming units of bacteria and less than 1 ng/ml of endotoxin. Sixteen patients died. They had higher median CRP (26.6 vs 11.2 mg/dl, P = 0.007) and lower median albumin levels (3.1 vs 3.9 g/l, P < 0.05) compared to the 31 survivors. Eight patients were excluded because of obvious inflammatory conditions. From the 23 remaining patients (mean age ± SD: 51.3 ± 13.9 years), 18 had a decrease in CRP after the water treatment system was changed. Overall, median CRP was lower with reverse osmosis than with deionization (13.2 vs 4.5 mg/l, P = 0.022, N = 23). There was no difference in albumin, cytokines, subjective global evaluation, or clinical and biochemical parameters. In conclusion, uremic patients presented a clinically significant reduction in CRP levels when dialysate water purification system switched from deionization to reverse osmosis. It is possible that better water treatments induce less inflammation and eventually less atherosclerosis in hemodialysis patients.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2005000500018HemodialysisC-reactive proteinDialysate waterReverse osmosiInflammationUremia
spellingShingle F.S. Thomé
M. Senger
C. Garcez
J. Garcez
C. Chemello
R.C. Manfro
Dialysis water treated by reverse osmosis decreases the levels of C-reactive protein in uremic patients
Brazilian Journal of Medical and Biological Research
Hemodialysis
C-reactive protein
Dialysate water
Reverse osmosi
Inflammation
Uremia
title Dialysis water treated by reverse osmosis decreases the levels of C-reactive protein in uremic patients
title_full Dialysis water treated by reverse osmosis decreases the levels of C-reactive protein in uremic patients
title_fullStr Dialysis water treated by reverse osmosis decreases the levels of C-reactive protein in uremic patients
title_full_unstemmed Dialysis water treated by reverse osmosis decreases the levels of C-reactive protein in uremic patients
title_short Dialysis water treated by reverse osmosis decreases the levels of C-reactive protein in uremic patients
title_sort dialysis water treated by reverse osmosis decreases the levels of c reactive protein in uremic patients
topic Hemodialysis
C-reactive protein
Dialysate water
Reverse osmosi
Inflammation
Uremia
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2005000500018
work_keys_str_mv AT fsthome dialysiswatertreatedbyreverseosmosisdecreasesthelevelsofcreactiveproteininuremicpatients
AT msenger dialysiswatertreatedbyreverseosmosisdecreasesthelevelsofcreactiveproteininuremicpatients
AT cgarcez dialysiswatertreatedbyreverseosmosisdecreasesthelevelsofcreactiveproteininuremicpatients
AT jgarcez dialysiswatertreatedbyreverseosmosisdecreasesthelevelsofcreactiveproteininuremicpatients
AT cchemello dialysiswatertreatedbyreverseosmosisdecreasesthelevelsofcreactiveproteininuremicpatients
AT rcmanfro dialysiswatertreatedbyreverseosmosisdecreasesthelevelsofcreactiveproteininuremicpatients